IL-12: A Versatile Protein Involved in Immune and Inflammatory Responses

Target Name: Interleukin-12 (IL-12)

NCBI ID: P5833

Interleukin-12 (IL-12)

Other Name(s): IL-12

IL-12: A Versatile Protein Involved in Immune and Inflammatory Responses

Interleukin-12 (IL-12) is a cytokine that plays a crucial role in the regulation of immune and inflammatory responses. It is a key player in the interferon pathway, which is a complex signaling pathway that regulates the production of intracellular signaling molecules. Activated immune cells produce IFN-纬, which activates the downstream signaling cascade, resulting in the production of pro-inflammatory cytokines.

IL-12 is a single transmembrane protein that is expressed in a variety of tissues, including the liver, spleen, and lymphoid organs. It is a potent regulator of immune cell function and has been implicated in a wide range of biological processes.

IL-12 is involved in the regulation of immune cell proliferation and differentiation. It promotes the production of CD4+ and CD8+ T cells, which are crucial for the immune response. CD4+ T cells are responsible for cell-mediated immunity, while CD8+ T cells are responsible for the production of antibodies as part of their immune response. IL-12 also regulates the production of natural killer cells and T regulatory cells, which are important for the regulation of immune cell function.

IL-12 is involved in the regulation of inflammation. It has been shown to play a role in the regulation of inflammatory responses, including the regulation of pain. IL-12 has been shown to reduce pain sensitivity in animal models of inflammation.

IL-12 is also involved in the regulation of cellular processes such as cell adhesion, migration and the production of pro-inflammatory cytokines.

IL-12 has been shown to be a potential drug target in the treatment of a wide range of diseases. For example, in rheumatoid arthritis (RA) IL-12 has been shown to be decreased in patients compared to healthy controls. Also, in cancer patients, IL-12 production is often increased and it has been shown to be a potential predictor of tumor response to chemotherapy.

In addition, IL-12 has also been shown to be involved in the regulation of obesity, as it has been shown to increase in obese individuals compared to healthy controls.

Overall, IL-12 is a highly versatile protein that plays a crucial role in the regulation of immune and inflammatory responses. Its potential as a drug target makes it an attractive target for the development of new treatments for a wide range of diseases. Further research is needed to fully understand the role of IL-12 in the regulation of immune and inflammatory responses and to develop effective treatments.

Protein Name: Interleukin-12 (IL-12)

The "Interleukin-12 (IL-12) Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Interleukin-12 (IL-12) comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets